Oxysterols as therapeutic targets
- PMID: 34278569
- DOI: 10.1111/bph.15577
Oxysterols as therapeutic targets
References
REFERENCES
-
- Aklillu, E., Zumla, A., Habtewold, A., Amogne, W., Makonnen, E., Yimer, G., Burhenne, J., & Diczfalusy, U. (2021). Early or deferred initiation of efavirenz during rifampicin-based TB therapy has no significant effect on CYP3A induction in TB-HIV infected patients. British Journal of Pharmacology, 178, 3294-3308. https://doi.org/10.1111/bph.15309
-
- Brown, A. J., & Jessup, W. (1999). Oxysterols and atherosclerosis. Atherosclerosis, 142, 1-28. https://doi.org/10.1016/S0021-9150(98)00196-8
-
- Brown, A. J., Sharpe, L. J., & Rogers, M. J. (2021). Oxysterols: From physiological tuners to pharmacological opportunities. British Journal of Pharmacology, 178, 3089-3103. https://doi.org/10.1111/bph.15073
-
- Buñay, J., Fouache, A., Trousson, A., Joussineau, C., Bouchareb, E., Zhu, Z., Kocer, A., Morel, L., Baron, S., & Lobaccaro, J. M. A. (2021). Screening for liver X receptor modulators: Where are we and for what use? British Journal of Pharmacology, 178, 3277-3293. https://doi.org/10.1111/bph.15286
-
- de Medina, P., Diallo, K., Huc-Claustre, E., Attia, M., Soulès, R., Silvente-Poirot, S., & Poirot, M. (2021). The 5,6-epoxycholesterol metabolic pathway in breast cancer: Emergence of new pharmacological targets. British Journal of Pharmacology, 178, 3248-3260. https://doi.org/10.1111/bph.15205
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources